$106.42
2.02% today
NYSE, Apr 02, 09:45 pm CET
ISIN
US7140461093
Symbol
RVTY

PerkinElmer Stock price

$104.31
-6.08 5.51% 1M
-20.13 16.18% 6M
-7.30 6.54% YTD
+1.04 1.01% 1Y
-67.26 39.20% 3Y
+33.48 47.27% 5Y
+53.71 106.15% 10Y
NYSE, Closing price Tue, Apr 01 2025
-1.49 1.41%
ISIN
US7140461093
Symbol
RVTY
Sector

Key metrics

Market capitalization $12.53b
Enterprise Value $14.69b
P/E (TTM) P/E ratio 43.30
EV/FCF (TTM) EV/FCF 27.13
EV/Sales (TTM) EV/Sales 5.33
P/S ratio (TTM) P/S ratio 4.55
P/B ratio (TTM) P/B ratio 1.64
Dividend yield 0.27%
Last dividend (FY24) $0.28
Revenue growth (TTM) Revenue growth 0.16%
Revenue (TTM) Revenue $2.76b
EBIT (operating result TTM) EBIT $410.52m
Free Cash Flow (TTM) Free Cash Flow $541.65m
Cash position $1.16b
EPS (TTM) EPS $2.41
P/E forward 42.82
P/S forward 4.43
EV/Sales forward 5.19
Short interest 6.11%
Show more

Is PerkinElmer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

PerkinElmer Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a PerkinElmer forecast:

13x Buy
62%
7x Hold
33%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a PerkinElmer forecast:

Buy
62%
Hold
33%
Sell
5%

Financial data from PerkinElmer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,755 2,755
0% 0%
100%
- Direct Costs 1,270 1,270
2% 2%
46%
1,485 1,485
2% 2%
54%
- Selling and Administrative Expenses 450 450
12% 12%
16%
- Research and Development Expense 197 197
9% 9%
7%
838 838
1% 1%
30%
- Depreciation and Amortization 428 428
1% 1%
16%
EBIT (Operating Income) EBIT 411 411
3% 3%
15%
Net Profit 296 296
59% 59%
11%

In millions USD.

Don't miss a Thing! We will send you all news about PerkinElmer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PerkinElmer Stock News

Neutral
Business Wire
about 8 hours ago
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT™.TB test. Initially launched outside the U.S. in 2024, this powerful combination allows laboratories to improve productivity while maintaining superior clinical performance in latent tuberculosis (T...
Neutral
Business Wire
about 8 hours ago
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals Software, will launch its Signals One™, a unified software platform evolved from the Company's existing research portfolio, designed to streamline data management across the entire drug discovery lifecycle. The Signals One platform addresses the growing complexity of drug ...
Neutral
Business Wire
13 days ago
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity announced an agreement with Genomics England to further collaborate on the Generation Study by providing sequencing services.
More PerkinElmer News

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Head office United States
CEO Prahlad Singh
Employees 11,000
Founded 1937
Website www.revvity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today